Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Kobold

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
Cancer Immunology Research|August 6, 2017
Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer ImmunotherapyKerstin Wennhold, Martin Thelen, Hans Anton Schlößer, et al.
Hemasphere|January 14, 2025
Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphomaSophia Stock, Veit L Bücklein, Viktoria Blumenberg, et al.
Plos One|June 11, 2025
Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infectionNikolas Weigl, Claire Pleimelding, Leonard Gilberg, et al.
Journal of the National Cancer Institute|November 27, 2014
Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transferSebastian Kobold, Julius Steffen, Michael Chaloupka, et al.
Leukemia Research|April 23, 2010
Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemiaTim Luetkens, Phillipe Schafhausen, Frederike Uhlich, et al.
Haematologica|September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemiaClaudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
British Journal of Cancer|July 3, 2023
Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapyTheo Lorenzini, Bruno L Cadilha, Hannah Obeck, et al.
Nature Biomedical Engineering|June 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyondMar Guaza-Lasheras, Johanna Nimmerfroh, Dominic Schwarz, et al.
Nature Communications|October 27, 2023
Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogrammingHao Wu, Xiufeng Zhao, Sophia M Hochrein, et al.
Leukemia|November 20, 2019
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockadeMichael Ruzicka, Lars M Koenig, Simone Formisano, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Cancer Immunology Research|August 6, 2017
Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer ImmunotherapyKerstin Wennhold, Martin Thelen, Hans Anton Schlößer, et al.
Hemasphere|January 14, 2025
Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphomaSophia Stock, Veit L Bücklein, Viktoria Blumenberg, et al.
Plos One|June 11, 2025
Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infectionNikolas Weigl, Claire Pleimelding, Leonard Gilberg, et al.
Journal of the National Cancer Institute|November 27, 2014
Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transferSebastian Kobold, Julius Steffen, Michael Chaloupka, et al.
Leukemia Research|April 23, 2010
Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemiaTim Luetkens, Phillipe Schafhausen, Frederike Uhlich, et al.
Haematologica|September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemiaClaudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
British Journal of Cancer|July 3, 2023
Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapyTheo Lorenzini, Bruno L Cadilha, Hannah Obeck, et al.
Nature Biomedical Engineering|June 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyondMar Guaza-Lasheras, Johanna Nimmerfroh, Dominic Schwarz, et al.
Nature Communications|October 27, 2023
Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogrammingHao Wu, Xiufeng Zhao, Sophia M Hochrein, et al.
Leukemia|November 20, 2019
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockadeMichael Ruzicka, Lars M Koenig, Simone Formisano, et al.
Pageof 18